Jeff Knight
Chief Operating Officer at CRINETICS PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Jeff E Knight is currently the Chief Operating Officer at Crinetics Pharmaceuticals, Inc. He previously worked as the Executive Director-Global Development Operations at Amgen, Inc. from 2015 to 2017, as the VP-Clinical Operations & Project Management at Onyx Pharmaceuticals, Inc. from 2012 to 2015, as the VP-Development Operations & Portfolio Management at Halozyme Therapeutics, Inc. from 2017 to 2018, and as the SVP-Portfolio Management & Corporate Operations at Poseida Therapeutics, Inc. from 2018 to 2021.
Mr. Knight received his undergraduate degree from the University of Kansas and his graduate degree from the University of Oklahoma.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-21 | 52,580 ( 0.07% ) | 2 M $ | 2024-03-30 |
Jeff Knight active positions
| Companies | Position | Start |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Chief Operating Officer | 2021-08-29 |
Former positions of Jeff Knight
| Companies | Position | End |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-08-30 |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-09-30 |
| AMGEN INC. | Corporate Officer/Principal | 2017-02-28 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 2015-06-30 |
Training of Jeff Knight
| University of Kansas | Undergraduate Degree |
| University of Oklahoma | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Stock Market
- Insiders
- Jeff Knight
